NCT04185844Recruiting
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 504 (estimated)
- First submitted
- 22 Nov 2019
- Start date
- 31 Aug 2020
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- University of New Mexico
- Diseases
- Chronic kidney disease
- NCT number
- NCT04185844
What you commit to
- Study type: Observational
- Planned participants: 504
- From 31 Aug 2020 to the primary completion date, 31 Jul 2028
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- End stage renal disease or renal transplant;
- renal cancer;
- Polycystic kidney disease;
Age
- life expectancy \<3 years;
Other
- Unable or unwilling to provide informed consent
- institutionalized subjects;
- myeloma;
- immunosuppression;
- participation in any clinical trial,
- current pregnancy
- current incarceration.
- Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.
Who the study is looking for
- Glomerular Filtration Rate (GFR): eGFR of =\>61\<80 and microalbuminuria \> 30 or eGRF of =\<60 (no microalbuminuria required).
Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| First Nations Community Health Source Coordinator of this site? Confirm its status | Albuquerque | United States | Recruiting |
| Zuni Health Initiative Center Coordinator of this site? Confirm its status | Black Rock | United States | Recruiting |
| NIDDK-Phoenix Epidemiology and Clinical Research Coordinator of this site? Confirm its status | Phoenix | United States | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.